NCT06261255

Brief Summary

The goal of this prospective case series is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level. The main question it aims to answer is: \- What is the benefit, in terms of clinical attachment level, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally protocol of tooth autotransplantation.Only one group (test) is assessed. It will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

3.3 years

First QC Date

January 30, 2024

Last Update Submit

February 7, 2024

Conditions

Keywords

emdogainenamel matrix derivativestooth autotransplantationtooth autogenous transplantationdigital planning

Outcome Measures

Primary Outcomes (1)

  • Clinical attachment level (CAL)

    CAL level changes on the donor tooth between the baseline situation and the last follow up visit.

    through study completion, an average of 1 year

Study Arms (1)

ATT + EMD

EXPERIMENTAL

There is only 1 arm, autotransplantation (ATT) + adjunctive EMD

Procedure: ATT + EMD

Interventions

ATT + EMDPROCEDURE

All surgical treatments will be performed by the same experienced periodontist (IP) after the administration of local anesthesia. Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the remaining fragments will be extracted as minimally invasively as possible. A tooth-supported surgical guide will be used to prepare the recipient site following the 3D planning. Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt the CARP model to the virtual planning position. The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if osteotomy is required, and avoiding the use of elevators or forceps over the root surface. Extraorally, EMD will be applied to the root surface of the donor tooth

ATT + EMD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults (≥18 years old) capable of providing informed consent, teeth deemed unrestorable and in need of replacement
  • presence of a viable, healthy, periodontally stable, and nonfunctional tooth (e.g., third molar) suitable for autotransplantation
  • periodontally healthy individuals or those with stable periodontal conditions after periodontal therapy.

You may not qualify if:

  • clinical attachment loss of the donor teeth
  • compromised general health or patients with systemic diseases that could influence the therapy outcome (uncontrolled diabetes mellitus, bone disorders, etc.)
  • pregnant or nursing women
  • chronic use of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immune-modulator drugs
  • patients requiring medications that affect bone metabolism (bisphosphonates)
  • chronic oral mucosa diseases
  • evident signs of severe bruxism or clenching habits
  • smokers of more than 10 cigarettes per day
  • non-compliant patients with 25% plaque index at the time of re-evaluation after non-surgical periodontal therapy and oral hygiene instructions
  • patients unable to attend study-related procedures and follow-up visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidad Complutense de Madrid

Madrid, 28003, Spain

Location

Universidad Complutense Madrid

Madrid, Spain

Location

MeSH Terms

Conditions

Tooth Loss

Interventions

emerin

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesTooth Diseases

Study Officials

  • Ignacio Pedrinaci, DDS

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This clinical investigation is a single-center, prospective case series study and is reported in compliance with the Preferred Reporting of Case Series in Surgery (PROCESS) guidelines. The study was conducted at the Department of Periodontology of the University Complutense of Madrid between March 2021 and September 2023.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Principal investigator

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 15, 2024

Study Start

June 1, 2020

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations